Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy Prospective randomized study

被引:47
作者
Cheema, Rizwan A. [1 ,2 ]
Al-Mubarak, Mahdi M. [2 ]
Amin, Yasir M. [2 ]
Cheema, Maheera A.
机构
[1] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales
[2] Dhahran Eye Specialist Hosp, Vitreo Retinal Serv, Dhahran, Saudi Arabia
关键词
ENDOTHELIAL GROWTH-FACTOR; MACULAR EDEMA; LASER PHOTOCOAGULATION; NATURAL-HISTORY; VITREOUS LEVELS; PHACOEMULSIFICATION; AVASTIN; TRIAMCINOLONE; IMPLANTATION; MACULOPATHY;
D O I
10.1016/j.jcrs.2008.09.019
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To evaluate the role of intravitreal bevacizumab, an anti-vascular endothelial growth factor agent, injected at the time of cataract surgery on the postoperative progression of diabetic retinopathy (DR) and diabetic maculopathy. SETTING: Tertiary-care eye specialty hospital, Dhahran, Kingdom of Saudi Arabia. METHODS: Patients were randomized to a standardized procedure of phacoemulsification with intraocular lens implantation alone (control group) or to receive 1.25 mg intravitreal bevacizumab at the end of surgery (intervention group). Diabetic retinopathy and maculopathy were assessed at each postoperative visit during a 6-month follow-up. RESULTS: Sixty-eight eyes (68 patients) with DR and cataract were recruited for this prospective study. Progression of DR occurred in 15 (45.45%) of 33 eyes in the control group and 4 (11.42%) of 35 eyes in the intervention group (P=.002) Progression of diabetic maculopathy occurred in 17 eyes (51.51%) in the control group and 2 eyes (5.71%) in the intervention group (P=.0001). There was no statistically significant difference in postoperative visual acuity between the 2 groups (P=.772). Two eyes in the control group and none in the intervention group progressed to neovascular glaucoma. The mean postoperative central macular thickness and mean macular thickness were not statistically significantly different between the 2 groups (P=.874 and .942, respectively). CONCLUSION: Intravitreal administration of 1.25 mg bevacizumab at the time of cataract surgery was safe and effective in preventing the progression of DR and diabetic maculopathy in patients with cataract and DR.
引用
收藏
页码:18 / 25
页数:8
相关论文
共 44 条
  • [1] Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
    Adamis, AP
    Altaweel, M
    Bressler, NM
    Cunningham, ET
    Davis, MD
    Goldbaum, M
    Gonzales, C
    Guyer, DR
    Katz, B
    Patel, M
    [J]. OPHTHALMOLOGY, 2006, 113 (01) : 23 - 28
  • [2] INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY
    ADAMIS, AP
    MILLER, JW
    BERNAL, MT
    DAMICO, DJ
    FOLKMAN, J
    YEO, TK
    YEO, KT
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) : 445 - 450
  • [3] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [4] Prevalence of blindness and visual impairment among Jordanian diabetics
    Al-Till, MI
    Al-Bdour, MD
    Ajlouni, KM
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2005, 15 (01) : 62 - 68
  • [5] AREVALO JF, 2008, EYE IN PRESS
  • [6] Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
    Avery, Robert L.
    Pearlman, Joel
    Pieramici, Dante J.
    Rabena, Melvin D.
    Castellarin, Alessandro A.
    Nasir, Ma'an A.
    Giust, Matthew J.
    Wendel, Robert
    Patel, Arun
    [J]. OPHTHALMOLOGY, 2006, 113 (10) : 1695 - 1705
  • [7] Diabetic retinopathy progression and visual outcome after phacoemulsification in South-Asian and Afro-Caribbean patients with diabetes
    Chatterjee, S
    Savant, VV
    Stavrou, P
    [J]. EYE, 2004, 18 (06) : 575 - 579
  • [8] Effect of cataract surgery on the progression of diabetic retinopathy
    Chung, J
    Kim, MY
    Kim, HS
    Yoo, JS
    Lee, YC
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2002, 28 (04) : 626 - 630
  • [9] Ocular perfusion abnormalities in diabetes
    Ciulla, TA
    Harris, A
    Latkany, P
    Piper, HC
    Arend, O
    Garzozi, H
    Martin, B
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 (05): : 468 - 477
  • [10] EXTRACAPSULAR CATARACT-SURGERY WITH LENS IMPLANTATION IN DIABETICS WITH AND WITHOUT PROLIFERATIVE RETINOPATHY
    CUNLIFFE, IA
    FLANAGAN, DW
    GEORGE, NDL
    AGGARWAAL, RJ
    MOORE, AT
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1991, 75 (01) : 9 - 12